Allex

Withdrawn

This medicine's authorisation has been withdrawn

desloratadine

Overview

On 2 February 2004 the Marketing Authorisation Holder notified the European Commission of its decision to voluntarily withdraw the Markething Authorisation for Allex for commercial reasons. On 10 March 2004 the European Commission adopted the decision withdrawing the Marketing Authorisation for the medicinal product Allex.

Product information

Product details

• Name of medicine:
  Allex
• Active substance:
  desloratadine
• International non-proprietary name (INN) or common name:
  desloratadine
• Therapeutic area (MeSH):
  • Rhinitis, Allergic, Perennial
  • Urticaria
  • Rhinitis, Allergic, Seasonal
• Anatomical therapeutic chemical (ATC) code:
  R06AX27

Pharmacotherapeutic group

Antihistamines for systemic use

Therapeutic indication

Aerius is indicated for the relief of symptoms associated with:

• allergic rhinitis (see section 5.1)
• urticaria (see section 5.1)

Authorisation details

• EMA product number:
  EMEA/H/C/000312
• Marketing authorisation holder:
  Schering-Plough Europe

  SP Europe; Rue de Stalle, 73; B-1180 Bruxelles; Belgium

• Marketing authorisation issued:
  15/01/2001
• Withdrawal of marketing authorisation:
  10/03/2004